This audit covers six 8-K filings over the trailing twelve months; no 10-K, 10-Q, S-1/S-3, or DEF 14A filings were included in the data set, which materially limits the depth of what can be inferred and should be noted in any board discussion. Within that narrow window, the highest-signal item is your April 23, 2026 8-K (accession 0001493152-26-018621) disclosing an Item 3.01 event (notice of delisting/failure to satisfy a listing rule or transfer), followed by a second Item 3.01 filing on May 29, 2026 (0001493152-26-026412) — outside readers will treat clustered 3.01 items as an unresolved listing-compliance narrative. Your May 7, 2026 Item 4.02 filing (0001493152-26-021756) declaring non-reliance on previously issued financials is, standing alone, the single most consequential disclosure-language risk in the window and will anchor any short-seller memo written on CETY. That 4.02 sits between two financing 8-Ks (April 28 and June 8) each carrying Items 1.01/2.03 (and 3.02 in April) — sophisticated readers will read the sequence as: listing notice, dilutive financing, restatement, second listing notice, second financing, then an Item 5.02 officer change on June 30. The June 30 5.02 (0001493152-26-031289) closing the sequence is the item most likely to be quoted first in any outside write-up. Overall posture is ELEVATED-to-HIGH on the strength of the 4.02 and paired 3.01s; trajectory across the window is worsening. Recommend the IRO walk the audit committee through the 4.02 remediation status and the current listing-compliance plan before the next earnings call.
The combination of an Item 4.02 non-reliance filing, two separate Item 3.01 listing-compliance notices, two financing 8-Cs with new debt obligations, and an Item 5.02 officer change — all inside roughly ten weeks — is the disclosure profile outside risk desks screen for. Any one of these in isolation is manageable; the clustering is what elevates the posture.
Trajectory: worsening — The 3.01 on April 23 (0001493152-26-018621) was followed by a second 3.01 on May 29 (0001493152-26-026412), and the 4.02 on May 7 (0001493152-26-021756) preceded, rather than followed, the June 30 5.02 (0001493152-26-031289) — the sequence reads as unresolved rather than remediated.
Your May 7, 2026 8-K carries a standalone Item 4.02. In the taxonomy used by outside risk desks, a solo 4.02 is the highest-weighted single-item 8-K category, ranking above going-concern language and above officer departures.
Two Item 3.01 filings appear roughly five weeks apart (April 23 and May 29, 2026). A second 3.01 in the same window generally signals either a new deficiency or an escalation of the first, and is read as unresolved rather than cured.
Two 8-Ks carrying Items 1.01 and 2.03 (material definitive agreement and direct financial obligation) were filed on April 28 and June 8, 2026 — one immediately before and one roughly a month after the 4.02. The April 28 filing also carries Item 3.02 (unregistered equity issuance).
A June 30, 2026 8-K carries a standalone Item 5.02 (departure/appointment of directors or principal officers), landing after the 4.02, both 3.01s, and both financings. Standalone 5.02s filed close to a restatement are the pattern outside readers look for.
The April 28 financing 8-K carries internal cross-references (the structured feed flags item 1.01 referencing 3.01 language, and item 9.01 referencing 1.01). This is not a discrepancy — the filer-reported and detected items match — but the cross-references indicate the financing document itself discusses the listing-compliance situation.
The following questions an analyst is most likely to raise on the next earnings call, with framing suggestions. Each is rooted in a specific filing in the audit window.
The audit committee should treat the Item 4.02 filing (0001493152-26-021756) as the central item on its next agenda, with a written status update from management and the external auditor on scope, timing, and control implications. The two Item 3.01 filings raise a parallel question of whether listing-compliance risk has been adequately disclosed as a risk factor in prior periodic filings and whether the current remediation plan is realistic against the exchange's deadlines. The June 30 Item 5.02 change should be reviewed for any connection — real or perceived — to the restatement, since outside readers will assume a connection unless the record establishes otherwise. The committee should also confirm that the April 28 and June 8 financings were executed with appropriate disclosure of the then-known listing and restatement facts.
Board minutes should reflect that the audit committee received and reviewed a written 4.02 remediation timeline, including affected periods, responsible personnel, and expected restatement filing date. The risk register should be updated to reflect listing-compliance status with reference to both 3.01 filings and the current cure period. Minutes should document the reason for the June 30 officer transition and whether it was reviewed by the audit committee or nominating/governance committee. The register should also capture the sequencing question — restatement between two financings — with a note on counterparty disclosure. Finally, the committee should document its review of ICFR implications and whether a material weakness conclusion is anticipated in the next periodic report.
The filings data supplied contains only 8-Ks — no 10-K, 10-Q, S-3, S-1, 424B, DEF 14A, or Form 4 filings were included, so this audit surfaces no findings on ATM cadence, shelf capacity, insider selling patterns, going-concern language, auditor changes (Item 4.01 was not present), or executive compensation. No Item 8.01 (other events) or Item 7.01 (Regulation FD) disclosures appeared in the window. No discrepancies between filer-reported items and detected items were flagged in any of the six 8-Ks, which is a modest positive on filing hygiene.
This audit reviews the six 8-Ks filed in the trailing twelve months and scores each against a fixed taxonomy of disclosure-risk signals used by outside risk desks: non-reliance (4.02), listing compliance (3.01), auditor change (4.01), officer/director change (5.02), unregistered issuance (3.02), material agreements and direct financial obligations (1.01/2.03), and item-clustering patterns. Severity is assigned on a three-band scale (high/medium/low) based on the signal type, whether it appears in isolation or clustered with other signals, and whether filer-reported items match detected items. The overall posture band reflects the highest-severity signal weighted by clustering and trajectory across the window. Sources are limited to SEC EDGAR structured filing metadata and item-level content; this audit does NOT incorporate stock price, trading volume, short interest, options activity, analyst notes, message-board sentiment, or any non-filings data. Because the supplied data set contains only 8-Ks, findings on periodic-report language, risk-factor evolution, and MD&A tone are outside the scope of this engagement and should be commissioned separately if desired.